Scott C. Chappel

Scott C. Chappel

Plus aucun poste en cours
75 ans
Health Technology
Consumer Services
Finance

Profil

Scott C.
Chappel
is the founder of Arteaus Therapeutics LLC, which was founded in 2011.
He held the title of Chief Scientific Officer from 2011 to 2014.
Dr. Chappel's former jobs include Research Director at Integrated Genetics, Inc., Senior Vice President-Research at Diacrin, Inc. (Delaware), and Senior Vice President-Research at Dyax Corp.
He also held the title of Vice President-Research at EMD Serono, Inc. and Venture Partner at Apple Tree Venture Management Llc.
Dr. Chappel was Chief Scientific Officer at Annovation BioPharma, Inc. from 2013 to 2014, Chief Scientific Officer at OvaScience, Inc. from 2011 to 2013, and Chief Technology Officer at Surface Oncology, Inc. Dr. Chappel's education includes an undergraduate degree from The Pennsylvania State University and a doctorate from the University of Maryland Medical Center.

Anciens postes connus de Scott C. Chappel

SociétésPosteFin
SURFACE ONCOLOGY, INC. Directeur Technique/Scientifique/R&D 01/06/2018
Fondateur 01/01/2014
Directeur Technique/Scientifique/R&D 01/01/2014
Directeur Technique/Scientifique/R&D 31/07/2013
Directeur Technique/Scientifique/R&D 01/01/2011
Voir l'expérience en détail de Scott C. Chappel

Formation de Scott C. Chappel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

26

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Scott C. Chappel